TRP Channels as Novel Targets for Endogenous Ligands: Focus on Endocannabinoids and Nociceptive Signalling

Abstract

Background: Chronic pain is a significant clinical problem and a very complex pathophysiological phenomenon. There is growing evidence that targeting the endocannabinoid system may be a useful approach to pain alleviation. Classically, the system includes G protein-coupled receptors of the CB1 and CB2 subtypes and their endogenous ligands. More recently, several subtypes of the large superfamily of cation TRP channels have been coined as “ionotropic cannabinoid receptors”, thus highlighting their role in cannabinoid signalling. Thus, the aim of this review was to explore the intimate connection between several “painful” TRP channels, endocannabinoids and nociceptive signalling.Methods: Research literature on this topic was critically reviewed allowing us not only summarize the existing evidence in this area of research, but also propose several possible cellular mechanisms linking nociceptive and cannabinoid signaling with TRP channels.Results: We begin with an overview of physiology of the endocannabinoid system and its major components, namely CB1 and CB2 G protein-coupled receptors, their two most studied endogenous ligands, anandamide and 2-AG, and several enzymes involved in endocannabinoid biosynthesis and degradation. The role of different endocannabinoids in the regulation of synaptic transmission is then discussed in detail. The connection between the endocannabinoid system and several TRP channels, especially TRPV1-4, TRPA1 and TRPM8, is then explored, while highlighting the role of these same channels in pain signalling.Conclusion: There is increasing evidence implicating several TRP subtypes not only as an integral part of the endocannabinoid system, but also as promising molecular targets for pain alleviation with the use of endo- and phytocannabinoids, especially when the function of these channels is upregulated under inflammatory conditions.

Metabolic syndrome and osteoarthritis pain: common molecular mechanisms and potential therapeutic implications

“…Furthermore, anandamide is an endogenous cannabinoid that controls appetite and energy balance, and is a selective endogenous TRPV1 partial agonist, i.e., its action on TRPV1 reduces pain 9 . Several studies have demonstrated important roles for the peripheral endocannabinoid system, including anandamide, in the regulation of energy metabolism.…”

The role of the endocannabinoid system in aetiopathogenesis of endometriosis: A potential therapeutic target

“…The transient receptor potential vanilloid type 1 (TRPV1) and transient receptor potential ankyrin-type1 (TRPA1) receptors are structurally related ligand-gated Ca 2+ permeable ion channels that are considered as an integral part of the ECS [38]. They are molecular integrators of a broad range of inflammatory stimuli including prostaglandins and AEA and play crucial roles in pain and inflammation [39].…”

Irritable Bowel Syndrome: Manipulating the Endocannabinoid System as First-Line Treatment

“…Other components of the ECS are the transient receptor potential (TRP) channels, such as TRPV1, TRM8, and others (Storozhuk and Zholos, 2018). These receptors, widely expressed throughout the digestive tract, are involved in numerous processes: taste, chemo-and mechanosensation, thermoregulation, pain and hyperalgesia, mucosal function, gut homeostasis, and control of motility, amongst others (Kaneko and Szallasi, 2014).…”